NASDAQ:ICLR - ICON Public Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $183.30
  • Forecasted Upside: -4.10 %
  • Number of Analysts: 11
  • Breakdown:
  • 0 Sell Ratings
  • 7 Hold Ratings
  • 4 Buy Ratings
  • 0 Strong Buy Ratings
$191.14
▲ +2.89 (1.54%)
1 month | 3 months | 12 months
Get New ICON Public Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for ICLR and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ICLR

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$183.30
▼ -4.10% Downside Potential
This price target is based on 11 analysts offering 12 month price targets for ICON Public in the last 3 months. The average price target is $183.30, with a high forecast of $235.00 and a low forecast of $140.00. The average price target represents a -4.10% upside from the last price of $191.14.
Hold
The current consensus among 11 contributing investment analysts is to hold stock in ICON Public. This rating has held steady since April 2020, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 7 buy ratings
  • 3 hold ratings
  • 0 sell ratings
6/8/2019
  • 0 strong buy ratings
  • 6 buy ratings
  • 3 hold ratings
  • 0 sell ratings
9/6/2019
  • 0 strong buy ratings
  • 6 buy ratings
  • 2 hold ratings
  • 0 sell ratings
12/5/2019
  • 0 strong buy ratings
  • 5 buy ratings
  • 5 hold ratings
  • 0 sell ratings
3/4/2020
  • 0 strong buy ratings
  • 5 buy ratings
  • 6 hold ratings
  • 0 sell ratings
6/2/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 7 hold ratings
  • 0 sell ratings
8/31/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 7 hold ratings
  • 0 sell ratings
10/30/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 7 hold ratings
  • 0 sell ratings
11/29/2020

Latest Recommendations

  • 0 strong buy ratings
  • 4 buy ratings
  • 7 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
10/23/2020Deutsche Bank AktiengesellschaftBoost Price TargetHold$170.00 ➝ $179.00Medium
i
10/23/2020MizuhoBoost Price TargetBuy$195.00 ➝ $217.00Medium
i
10/22/2020Credit Suisse GroupBoost Price TargetOutperform$230.00 ➝ $235.00Medium
i
7/27/2020UBS GroupBoost Price TargetNeutral$188.00 ➝ $194.00Low
i
7/27/2020Deutsche Bank AktiengesellschaftBoost Price TargetHold$135.00 ➝ $170.00Low
i
7/27/2020MizuhoBoost Price TargetBuy$170.00 ➝ $195.00Low
i
7/24/2020Bank of AmericaDowngradeBuy ➝ NeutralLow
i
7/24/2020Jefferies Financial GroupBoost Price TargetBuy$184.00 ➝ $220.00Low
i
7/23/2020Credit Suisse GroupBoost Price TargetOutperform$181.00 ➝ $205.00High
i
4/27/2020SunTrust BanksBoost Price TargetHold$131.00 ➝ $157.00Medium
i
Rating by Sandy Draper at SunTrust Banks, Inc.
4/24/2020Deutsche Bank AktiengesellschaftLower Price TargetHold$169.00 ➝ $135.00Medium
i
4/23/2020Credit Suisse GroupLower Price TargetOutperform$187.00 ➝ $181.00High
i
4/23/2020BarclaysBoost Price TargetOverweight$170.00 ➝ $180.00High
i
4/20/2020Robert W. BairdDowngradeOutperform ➝ Neutral$151.00Low
i
4/9/2020CitigroupLower Price TargetNeutral$185.00 ➝ $160.00Medium
i
4/3/2020MizuhoLower Price TargetBuy$180.00 ➝ $154.00Low
i
3/30/2020Wells Fargo & CompanyLower Price TargetEqual Weight$180.00 ➝ $140.00Low
i
3/26/2020BarclaysUpgradeEqual Weight ➝ Overweight$182.00 ➝ $170.00High
i
3/23/2020Jefferies Financial GroupLower Price TargetBuy$180.00 ➝ $146.00High
i
3/17/2020SunTrust BanksLower Price TargetHold$182.00 ➝ $131.00Medium
i
Rating by Sandy Draper at SunTrust Banks, Inc.
3/2/2020Deutsche Bank AktiengesellschaftInitiated CoverageHold$169.00High
i
2/21/2020UBS GroupBoost Price TargetNeutral$174.00 ➝ $182.00Medium
i
Rating by Daniel Brennan at UBS Group AG
2/20/2020BarclaysBoost Price TargetEqual Weight$168.00 ➝ $182.00High
i
2/20/2020MizuhoReiterated RatingBuy$179.00 ➝ $194.00High
i
1/27/2020SunTrust BanksDowngradeBuy ➝ Hold$170.00 ➝ $182.00Medium
i
1/7/2020Wells Fargo & CompanyInitiated CoverageEqual Weight$180.00Low
i
1/6/2020CitigroupInitiated CoverageNeutral$185.00Low
i
10/28/2019Credit Suisse GroupReiterated RatingBuy$160.00Low
i
10/25/2019UBS GroupSet Price TargetHold$160.00N/A
i
Rating by Daniel Brennan at UBS Group AG
10/18/2019UBS GroupLower Price TargetNeutral$171.00 ➝ $158.00Low
i
8/8/2019KeyCorpBoost Price TargetOverweight$157.00 ➝ $165.00Medium
i
7/26/2019UBS GroupUpgradeSell ➝ Neutral$135.00 ➝ $171.00Low
i
7/25/2019MizuhoBoost Price TargetBuy$160.00 ➝ $170.00High
i
Rating by Ann Hynes at Mizuho
6/11/2019MizuhoBoost Price TargetBuy$154.00 ➝ $160.00Low
i
Rating by Ann Hynes at Mizuho
4/17/2019BarclaysReiterated RatingHold$154.00High
i
4/2/2019Wolfe ResearchInitiated CoverageOutperformLow
i
3/18/2019BarclaysBoost Price TargetEqual Weight ➝ Equal Weight$140.00 ➝ $148.00Low
i
2/25/2019SunTrust BanksReiterated RatingBuy$161.00Medium
i
2/21/2019BarclaysBoost Price TargetEqual Weight ➝ Equal Weight$130.00 ➝ $140.00Low
i
1/25/2019MizuhoUpgradeNeutral ➝ Buy$146.00 ➝ $150.00Medium
i
Rating by Ann Hynes at Mizuho
12/14/2018The Goldman Sachs GroupDowngradeConviction-Buy ➝ Buy$168.00Medium
i
10/27/2018UBS GroupSet Price TargetSell$136.00Medium
i
Rating by Daniel Brennan at UBS Group AG
10/26/2018Evercore ISIUpgradeIn-Line ➝ OutperformMedium
i
10/9/2018UBS GroupInitiated CoverageSell ➝ Sell$145.00Medium
i
9/11/2018Robert W. BairdBoost Price TargetOutperform ➝ Outperform$154.00 ➝ $157.00Low
i
9/11/2018KeyCorpBoost Price TargetOverweight ➝ Overweight$152.00 ➝ $157.00Low
i
8/6/2018MizuhoSet Price TargetHold$146.00Medium
i
Rating by Ann Hynes at Mizuho
7/26/2018Robert W. BairdReiterated RatingBuy$154.00High
i
7/26/2018SunTrust BanksBoost Price TargetBuy$153.00High
i
6/19/2018Credit Suisse GroupBoost Price TargetOutperform ➝ Outperform$131.00 ➝ $144.00Medium
i
6/18/2018KeyCorpBoost Price TargetOverweight ➝ Overweight$130.00 ➝ $152.00Low
i
6/1/2018Jefferies Financial GroupBoost Price TargetBuy$150.00Medium
i
2/16/2018Credit Suisse GroupUpgradeBuy$131.00Low
i
2/15/2018MizuhoReiterated RatingNeutral ➝ Neutral$109.00 ➝ $114.00Low
i
Rating by Ann Hynes at Mizuho
1/24/2018MizuhoSet Price TargetHold$109.00Low
i
Rating by Ann Hynes at Mizuho
1/22/2018SunTrust BanksReiterated RatingBuy$133.00Low
i
1/18/2018Evercore ISIInitiated CoverageOutperform ➝ Outperform$126.00High
i
1/11/2018KeyCorpReiterated RatingBuy$130.00Medium
i
11/13/2017KeyCorpReiterated RatingOverweight$115.00 ➝ $125.00N/A
i
10/29/2017SunTrust BanksReiterated RatingReduce ➝ Buy$138.00N/A
i
10/27/2017BarclaysBoost Price TargetEqual Weight ➝ Equal Weight$108.00 ➝ $120.00N/A
i
10/16/2017Credit Suisse GroupReiterated RatingOutperform$105.00 ➝ $120.00N/A
i
10/12/2017Robert W. BairdReiterated RatingBuy$123.00N/A
i
10/9/2017Jefferies Financial GroupBoost Price TargetBuy$122.00 ➝ $132.00N/A
i
9/12/2017Jefferies Financial GroupReiterated RatingBuy$122.00Low
i
9/11/2017Bank of AmericaInitiated CoverageBuy ➝ Buy$128.00Low
i
7/31/2017KeyCorpReiterated RatingOverweightMedium
i
7/31/2017SunTrust BanksUpgradeHold ➝ Buy$93.00 ➝ $126.00Medium
i
7/30/2017Jefferies Financial GroupReiterated RatingBuyMedium
i
7/28/2017Credit Suisse GroupReiterated RatingBuyLow
i
7/27/2017MizuhoBoost Price TargetNeutral ➝ Neutral$104.00 ➝ $108.00Low
i
7/7/2017The Goldman Sachs GroupUpgradeBuy ➝ Conviction-Buy$117.00High
i
6/29/2017Jefferies Financial GroupUpgradeHold ➝ Buy$86.00 ➝ $117.00Medium
i
6/9/2017Robert W. BairdLower Price TargetOutperform$107.00 ➝ $97.00Low
i
6/6/2017Credit Suisse GroupReiterated RatingOutperform$91.00 ➝ $102.00Low
i
5/11/2017Jefferies Financial GroupReiterated RatingHoldLow
i
4/28/2017Evercore ISIBoost Price TargetOutperform$91.50 ➝ $92.00Low
i
3/23/2017MizuhoInitiated CoverageNeutral$66.00Low
i
1/24/2017Jefferies Financial GroupBoost Price TargetHold$84.00 ➝ $86.00N/A
i
1/6/2017Jefferies Financial GroupReiterated RatingHold$87.50 ➝ $84.00N/A
i
12/16/2016The Goldman Sachs GroupUpgradeNeutral ➝ Buy$86.00 ➝ $90.00N/A
i
12/16/2016SunTrust BanksDowngradeBuy ➝ Hold$95.00 ➝ $80.00N/A
i
10/24/2016Jefferies Financial GroupReiterated RatingHold$80.00 ➝ $87.50N/A
i
Rating by David Windley at Jefferies Financial Group Inc.
10/20/2016Avondale PartnersUpgradeUnderperform ➝ Market PerformN/A
i
Rating by G. Bolan at Avondale Partners
10/14/2016Evercore ISIUpgradeHold ➝ Buy$81.50 ➝ $89.00N/A
i
7/27/2016KeyCorpReiterated RatingBuy$85.00N/A
i
Rating by Donald Hooker at KeyCorp
7/27/2016Jefferies Financial GroupBoost Price TargetHold$78.00 ➝ $80.00N/A
i
Rating by David Windley at Jefferies Financial Group Inc.
7/26/2016Evercore ISIBoost Price TargetHold$76.00 ➝ $81.50N/A
i
6/27/2016Robert W. BairdReiterated RatingOutperform$83.00N/A
i
6/20/2016Credit Suisse GroupInitiated CoverageOutperform$80.00N/A
i
6/10/2016Jefferies Financial GroupReiterated RatingHold$78.00N/A
i
6/8/2016Avondale PartnersDowngradeMarket Perform ➝ Underperform$70.00 ➝ $59.00N/A
i
Rating by G. Bolan at Avondale Partners
6/3/2016Jefferies Financial GroupDowngradeBuy ➝ Hold$80.00 ➝ $78.00N/A
i
5/22/2016KeyCorpReiterated RatingBuyN/A
i
Rating by Donald Hooker at KeyCorp
5/11/2016Jefferies Financial GroupReiterated RatingBuy$80.00N/A
i
4/28/2016Jefferies Financial GroupReiterated RatingBuy$85.00 ➝ $80.00N/A
i
4/27/2016SunTrust BanksReiterated RatingBuyN/A
i
Rating by Sandy Draper at SunTrust Banks, Inc.
2/26/2016The Goldman Sachs GroupBoost Price TargetNeutral$75.00 ➝ $79.00N/A
i
(Data available from 11/29/2015 forward)
ICON Public logo
ICON Public Limited Company, a clinical research organization, provides outsourced development services to the pharmaceutical, biotechnology, and medical device industries in Ireland, rest of Europe, the United States, and internationally. It specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. The company's clinical development services include product development planning, strategic consulting, study protocol preparation, clinical pharmacology, pharmacokinetic and pharmacodynamic analysis, site feasibility, patient recruitment and retention, digital patient and site, project management, clinical operations/monitoring, patient centric monitoring, data management, and adaptive and virtual trial services. Its clinical development services also comprise medical imaging, biostatistics, medical affairs, pharmacovigilance, strategic regulatory, electronic endpoint adjudication, medical writing and publishing, interactive response technologies, functional, strategic resourcing central laboratory, bioanalytical laboratory, biomarket development, strategy and analytics, late phase research, patient centered science, and medical device and diagnostics research services, as well as access, commercialization, and communication services, and research trials for us government agencies. The company was founded in 1990 and is headquartered in Dublin, Ireland.
Read More

Today's Range

Now: $191.14
$188.72
$191.60

50 Day Range

MA: $195.01
$180.30
$214.08

52 Week Range

Now: $191.14
$104.28
$215.29

Volume

49,187 shs

Average Volume

253,334 shs

Market Capitalization

$10.25 billion

P/E Ratio

31.86

Dividend Yield

N/A

Beta

0.92